Current and future use of umifenovir in patients with COVID-19

At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental” nature of this treatment.

Bibliographic Details
Published in:Качественная клиническая практика
Main Authors: Yu. Yu. Kiselev, K. A. Zagorodnikova, D. V. Ivashchenko, A. V. Krykov, I. N. Sychev, A. S. Matveev, K. B. Mirzaev, V. A. Otdelenov, V. M. Tsvetov, A. V. Dmitriev, V. V. Poroikov, D. A. Sychev
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2020-10-01
Subjects:
коронавирус
умифеновир
covid-19
Online Access:https://www.clinvest.ru/jour/article/view/532
Description
Summary:At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental” nature of this treatment.
ISSN:2588-0519
2618-8473

Similar Items